RCMI Coordinating Center (RCMI CC) Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Sariol, Carlos A.
Item TypeName
Academic Article Decreased dengue replication and an increased anti-viral humoral response with the use of combined Toll-like receptor 3 and 7/8 agonists in macaques.
Academic Article An alphavirus vector-based tetravalent dengue vaccine induces a rapid and protective immune response in macaques that differs qualitatively from immunity induced by live virus infection.
Academic Article Dengue virus envelope protein domain I/II hinge determines long-lived serotype-specific dengue immunity.
Academic Article Zika virus pathogenesis in rhesus macaques is unaffected by pre-existing immunity to dengue virus.
Academic Article A Tale of Two Viruses: Does Heterologous Flavivirus Immunity Enhance Zika Disease?
Academic Article Effective control of early Zika virus replication by Dengue immunity is associated to the length of time between the 2 infections but not mediated by antibodies.
Academic Article Time elapsed between Zika and dengue virus infections affects antibody and T cell responses.
Academic Article Transcriptional activation of interferon-stimulated genes but not of cytokine genes after primary infection of rhesus macaques with dengue virus type 1.
Academic Article Absence of SHIV infection in gut and lymph node tissues in rhesus monkeys after repeated rectal challenges following HIV-1 DNA/MVA immunizations.
Concept Immunity
Concept Immunity, Cellular
Concept Immunity, Innate
Concept Immunity, Humoral
Academic Article Function Is More Reliable than Quantity to Follow Up the Humoral Response to the Receptor-Binding Domain of SARS-CoV-2-Spike Protein after Natural Infection or COVID-19 Vaccination.
Academic Article Implications of a highly divergent dengue virus strain for cross-neutralization, protection, and vaccine immunity.
Academic Article A live dengue virus vaccine carrying a chimeric envelope glycoprotein elicits dual DENV2-DENV4 serotype-specific immunity.
Search Criteria
  • Immunity
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support